156 related articles for article (PubMed ID: 15473055)
1. Immunochemical versus guaiac fecal occult blood tests.
Technol Eval Cent Assess Program Exec Summ; 2004 Jul; 19(5):1-3. PubMed ID: 15473055
[No Abstract] [Full Text] [Related]
2. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical fecal occult blood tests for colorectal cancer screening.
Allison JE
Am J Med; 2004 Apr; 116(7):498; author reply 498-9. PubMed ID: 15047043
[No Abstract] [Full Text] [Related]
5. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Fletcher RH; Ransohoff DF; Imperiale TF
Cancer; 2007 May; 109(9):1925-6; author reply 1926. PubMed ID: 17370313
[No Abstract] [Full Text] [Related]
6. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial.
Hoffman RM; Steel S; Yee EF; Massie L; Schrader RM; Murata GH
Prev Med; 2010; 50(5-6):297-9. PubMed ID: 20307568
[TBL] [Abstract][Full Text] [Related]
8. Which colorectal cancer screening test is best?
Mandel JS
J Natl Cancer Inst; 2007 Oct; 99(19):1424-5. PubMed ID: 17895471
[No Abstract] [Full Text] [Related]
9. From guaiac to immune fecal occult blood tests: the emergence of technology in colorectal cancer screening.
Greenwald B
Gastroenterol Nurs; 2005; 28(2):90-6. PubMed ID: 15832108
[TBL] [Abstract][Full Text] [Related]
10. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.
Park DI; Ryu S; Kim YH; Lee SH; Lee CK; Eun CS; Han DS
Am J Gastroenterol; 2010 Sep; 105(9):2017-25. PubMed ID: 20502450
[TBL] [Abstract][Full Text] [Related]
11. Fecal occult blood testing when colonoscopy capacity is limited.
Wilschut JA; Habbema JD; van Leerdam ME; Hol L; Lansdorp-Vogelaar I; Kuipers EJ; van Ballegooijen M
J Natl Cancer Inst; 2011 Dec; 103(23):1741-51. PubMed ID: 22076285
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
[TBL] [Abstract][Full Text] [Related]
13. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests.
Ko CW; Dominitz JA; Nguyen TD
Am J Med; 2003 Aug; 115(2):111-4. PubMed ID: 12893396
[TBL] [Abstract][Full Text] [Related]
14. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial.
Federici A; Giorgi Rossi P; Borgia P; Bartolozzi F; Farchi S; Gausticchi G
J Med Screen; 2005; 12(2):83-8. PubMed ID: 15949119
[TBL] [Abstract][Full Text] [Related]
15. Replacing guaiac-based tests with immunochemical tests in colorectal cancer screening.
Schlackman N
Am J Med; 2003 Aug; 115(2):154; author reply 154-5. PubMed ID: 12893403
[No Abstract] [Full Text] [Related]
16. New stool screening tests for colorectal cancer.
Young GP; Cole S
Digestion; 2007; 76(1):26-33. PubMed ID: 17947816
[TBL] [Abstract][Full Text] [Related]
17. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
18. New fecal occult blood tests may improve adherence and mortality rates.
Kumaravel V; Hayden SP; Hall GS; Burke CA
Cleve Clin J Med; 2011 Aug; 78(8):515-20. PubMed ID: 21807923
[TBL] [Abstract][Full Text] [Related]
19. A comparison of three stool tests for colorectal cancer screening.
Greenwald B
Medsurg Nurs; 2005 Oct; 14(5):292-9; quiz 300. PubMed ID: 16318108
[TBL] [Abstract][Full Text] [Related]
20. [Advantage of immunochemical fecal occult blood test in screening for colorectal cancer].
Launoy G; Berchi C
Bull Cancer; 2005 Oct; 92(10):885-90. PubMed ID: 16266872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
